|
Species
|
Study arm
|
SNP/status
|
n
|
Genotypic frequencies [x (%)]
|
Allelic frequencies [y (%)]
|
OR (95% CI)
|
|---|
|
RR
|
RS
|
SS
|
R
|
S
|
|---|
| | |
Kdr L1014F
| | | | | | | |
|
An. coluzzii
|
Control
|
Infected
|
213
|
102 (47.89)
|
96 (45.07)
|
15 (7.04)
|
300 (70.42)
|
126 (29.58)
|
1
|
|
Uninfected
|
208
|
102 (49.04)
|
86 (41.35)
|
20 (9.62)
|
290 (69.71)
|
126 (30.29)
|
1.03 (0.76–1.38)
|
|
SET
|
Infected
|
92
|
40 (43.48)
|
46 (50.00)
|
6 (6.52)
|
126 (68.48)
|
58 (31.52)
|
1
|
|
Uninfected
|
118
|
60 (50.85)
|
43 (36.44)
|
15 (12.71)
|
163 (69.07)
|
73 (30.93)
|
0.97 (0.62–1.5)
|
|
An. gambiae
|
Control
|
Infected
|
187
|
183 (97.86)
|
3 (1.60)
|
1 (0.53)
|
369 (98.66)
|
5 (1.35)
|
1
|
|
Uninfected
|
208
|
207 (99.52)
|
1 (0.47)
|
0 (0)
|
415 (99.76)
|
1 (0.24)
|
0.17 (0.003–1.6)
|
|
SET
|
Infected
|
119
|
117 (98.32)
|
2 (1.68)
|
0 (0)
|
236 (99.16)
|
2 (0.84)
|
1
|
|
Uninfected
|
110
|
109 (99.1)
|
1 (0.9)
|
0 (0)
|
219 (99.55)
|
1 (0.45)
|
0.53 (0.009–10.4)
|
| | |
Ace-1RG119S
| | | | | | | |
|
An. coluzzii
|
Control
|
Infected
|
213
|
4 (1.88)
|
23 (10.80)
|
186 (87.32)
|
31 (7.28)
|
395 (92.72)
|
1
|
|
Uninfected
|
207
|
8 (3.86)
|
29 (14.01)
|
170 (82.13)
|
45 (10.87)
|
369 (89.13)
|
0.64 (0.38–1.06)
|
|
SET
|
Infected
|
92
|
0 (0)
|
9 (9.78)
|
83 (90.22)
|
9 (4.89)
|
175 (95.11)
|
1
|
|
Uninfected
|
118
|
2 (1.69)
|
15 (12.71)
|
15 (85.60)
|
19 (8.05)
|
217 (91.95)
|
0.58 (0.22–1.40)
|
|
An. gambiae
|
Control
|
Infected
|
186
|
15 (8.06)
|
42 (22.58)
|
129 (69.35)
|
72 (19.32)
|
300 (80.64)
|
1
|
|
Uninfected
|
208
|
21 (10.10)
|
52 (25.00)
|
135 (64.90)
|
94 (22.60)
|
322 (77.40)
|
0.82 (0.57–1.17)
|
|
SET
|
Infected
|
119
|
7 (5.88)
|
25 (21.01)
|
87 (73.11)
|
39 (16.39)
|
199 (83.61)
|
1
|
|
Uninfected
|
109
|
9 (8.26)
|
19 (17.43)
|
81 (74.31)
|
37 (16.97)
|
181 (83.03)
|
0.95 (0.56–1.62)
|
- For the genotypic frequency distribution, values between infected and uninfected groups did not differ significantly (p > 0.05). For abbreviations, see Tables 1 and 2
